<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The Future: Prevention & Outlook</title>
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;700;900&family=Open+Sans:wght@400;600&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css" rel="stylesheet">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Roboto', sans-serif; background-color: #f0f2f5; display: flex; justify-content: center; align-items: center; height: 100vh; overflow: hidden; }
        
        .slide-container {
            width: 1280px;
            min-height: 720px;
            background-color: #FFFFFF;
            position: relative;
            overflow: hidden;
            display: flex;
            flex-direction: column;
            padding: 60px 80px 50px; /* keep top padding (60px) unchanged */
        }

        /* Header Section */
        .header-section {
            margin-bottom: 40px;
            border-left: 8px solid #3498DB;
            padding-left: 30px;
        }

        .slide-title {
            font-size: 48px;
            font-weight: 900;
            color: #2C3E50;
            margin-bottom: 10px;
        }

        .slide-subtitle {
            font-size: 24px;
            font-weight: 300;
            color: #7f8c8d;
            font-family: 'Open Sans', sans-serif;
        }

        /* Main Content Grid */
        .content-grid {
            display: flex;
            gap: 48px;
            height: 460px; /* reduced from 480px to shrink overall page height */
        }

        /* Left Column: Strategies */
        .strategy-column {
            flex: 3;
            display: flex;
            flex-direction: column;
            gap: 20px; /* reduced vertical gaps between blocks */
        }

        .strategy-block {
            background-color: #f8f9fa;
            border-radius: 12px;
            padding: 18px; /* reduced inner padding */
            border-left: 4px solid #ecf0f1;
        }

        .strategy-block.primary { border-left-color: #3498DB; }
        .strategy-block.innovation { border-left-color: #9b59b6; }
        .strategy-block.global { border-left-color: #27ae60; }

        .block-title {
            font-size: 20px;
            font-weight: 700;
            color: #2C3E50;
            margin-bottom: 10px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .block-text {
            font-size: 16px;
            color: #555;
            line-height: 1.5;
            font-family: 'Open Sans', sans-serif;
        }

        /* Right Column: Visual & Action */
        .visual-column {
            flex: 2;
            display: flex;
            flex-direction: column;
            gap: 30px;
        }

        .image-container {
            width: 100%;
            height: 230px; /* slightly reduced from 250px */
            border-radius: 15px;
            overflow: hidden;
            box-shadow: 0 10px 20px rgba(0,0,0,0.1);
            border: 4px solid white;
            position: relative;
        }

        .image-container img {
            width: 100%;
            height: 100%;
            object-fit: cover;
        }

        .cta-box {
            flex-grow: 1;
            background-color: #2C3E50;
            color: white;
            border-radius: 15px;
            padding: 24px; /* slightly reduced */
            display: flex;
            flex-direction: column;
            justify-content: center;
            align-items: center;
            text-align: center;
            box-shadow: 0 15px 30px rgba(44, 62, 80, 0.2);
        }

        .cta-icon {
            font-size: 40px;
            color: #E74C3C;
            margin-bottom: 15px;
        }

        .cta-title {
            font-size: 24px;
            font-weight: 900;
            margin-bottom: 10px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .cta-text {
            font-size: 16px;
            line-height: 1.6;
            opacity: 0.9;
            font-family: 'Open Sans', sans-serif;
        }

        /* Decorative Elements */
        .puzzle-piece-deco {
            position: absolute;
            bottom: 12px; /* moved up slightly */
            right: 20px;
            font-size: 100px;
            color: #f0f2f5;
            z-index: -1;
            transform: rotate(-15deg);
        }

    </style>
</head>
<body>
    <div class="slide-container">
        <div class="header-section">
            <h1 class="slide-title">The Future: Prevention & Outlook</h1>
            <h2 class="slide-subtitle">Breaking the cycle through innovation and action.</h2>
        </div>

        <div class="content-grid">
            <!-- Left Column -->
            <div class="strategy-column">
                <!-- Prevention -->
                <div class="strategy-block primary">
                    <div class="block-title">
                        <i class="fas fa-shield-alt" style="color: #3498DB;"></i>
                        Prevention Strategies
                    </div>
                    <p class="block-text">
                        <strong>Primary:</strong> Early lifestyle intervention in at-risk groups can prevent 20-30% of diagnoses.<br>
                        <strong>Secondary:</strong> Tight control prevents complications like stroke and kidney failure.
                    </p>
                </div>

                <!-- Innovation -->
                <div class="strategy-block innovation">
                    <div class="block-title">
                        <i class="fas fa-flask" style="color: #9b59b6;"></i>
                        Emerging Therapies
                    </div>
                    <p class="block-text">
                        <strong>Renal Denervation:</strong> A procedure to reduce sympathetic activity.<br>
                        <strong>New Agents:</strong> SGLT2 inhibitors and non-steroidal mineralocorticoid antagonists offer dual protection.
                    </p>
                </div>

                <!-- Global Impact -->
                <div class="strategy-block global">
                    <div class="block-title">
                        <i class="fas fa-globe-americas" style="color: #27ae60;"></i>
                        Global Impact Goal
                    </div>
                    <p class="block-text">
                        The WHO targets a <strong>25% reduction</strong> in prevalence by 2040, potentially saving <strong>9.4 million lives</strong> annually.
                    </p>
                </div>
            </div>

            <!-- Right Column -->
            <div class="visual-column">
                <div class="image-container">
                    <img src="/home/ubuntu/upload/search_images/zgvaWPEejJNz.jpg" alt="Solving the Healthcare Puzzle">
                </div>

                <div class="cta-box">
                    <i class="fas fa-heartbeat cta-icon"></i>
                    <h3 class="cta-title">Your Power to Change</h3>
                    <p class="cta-text">
                        Hypertension is manageable. <br>
                        <strong>Know your numbers.</strong> <br>
                        Take the first step today.
                    </p>
                </div>
            </div>
        </div>

        <i class="fas fa-puzzle-piece puzzle-piece-deco"></i>
    </div>
</body>
</html>
